Fred Hutchinson Cancer Center, formerly Seattle Cancer Care Alliance (SCCA), is a world-renowned cancer treatment and research institution based in Seattle, Washington. It unites comprehensive patient care with cutting-edge research to advance the prevention, diagnosis, and treatment of cancer. Fred Hutch provides compassionate, patient-centered care and is at the forefront of immunotherapy, transplantation, and precision oncology.
Serves as the central hub for advanced cancer research, patient treatment, clinical trials, and administrative operations for Fred Hutchinson Cancer Center.
State-of-the-art research laboratories, advanced clinical facilities, patient and family support services, and collaborative workspaces designed to foster innovation. The campus is part of the vibrant South Lake Union biotech hub.
A mission-driven, collaborative, and innovative environment focused on scientific discovery and compassionate patient care. Employees are dedicated to eradicating cancer and value teamwork, integrity, and excellence.
Represents a leading center for cancer research and treatment globally, known for pioneering work in bone marrow transplantation, immunotherapy, and precision medicine. Its location in Seattle's biotech hub facilitates collaboration and innovation.
While Fred Hutchinson Cancer Center's primary clinical operations are focused in the Pacific Northwest, its research and collaborations have a significant global impact. Fred Hutch engages in international research partnerships, particularly in areas like global oncology and infectious disease research (often linked to cancer, e.g., HPV, HIV). It trains scientists and physicians from around the world, and its discoveries influence cancer treatment protocols globally. Specific global health programs are active in regions like sub-Saharan Africa and Asia.
1100 Fairview Ave N
Seattle
WA
USA
Address: 825 Eastlake Ave E, Seattle, WA 98109
Serves as a key patient care facility for the Puget Sound region and beyond, offering access to specialized treatments and clinical trials.
Address: 1959 NE Pacific St, Seattle, WA 98195
Provides advanced inpatient cancer treatment and transplantation services, leveraging the resources of a major academic medical center.
Address: 19917 7th Ave NE, Suite 100, Poulsbo, WA 98370
Offers convenient access to high-quality cancer care for communities west of Puget Sound.
Address: 100 NE Gilman Blvd, Suite 100, Issaquah, WA 98027
Extends specialized cancer care to the Eastside communities, making treatment more accessible.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Fred Hutchinson Cancer Center (formerly Seattle Cancer Care Alliance)' leadership includes:
Fred Hutchinson Cancer Center (formerly Seattle Cancer Care Alliance) has been backed by several prominent investors over the years, including:
Fred Hutchinson Cancer Center has seen some key leadership transitions within its scientific divisions over the past 12-18 months, reflecting ongoing strategic development following its 2022 merger. These include appointments and departures of divisional directors who are crucial to the organization's research mission.
Discover the tools Fred Hutchinson Cancer Center (formerly Seattle Cancer Care Alliance) uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Fred Hutchinson Cancer Center (incorporating former SCCA personnel) likely uses standardized email formats common in large research and healthcare institutions. The most common format typically involves the first initial and last name, or combinations thereof.
Common formats include [first_initial][last_name]@fredhutch.org (e.g., jdoe@fredhutch.org) or [first_name].[last_name]@fredhutch.org (e.g., jane.doe@fredhutch.org). Variations may exist.
Format
jdoe@fredhutch.org
Example
85%
Success rate
Fred Hutch News Service • April 29, 2024
Fred Hutchinson Cancer Center announced a $10 million philanthropic gift from Stuart and Genevieve Ashmun to advance brain cancer research. The donation will establish the Ashmun Endowed Professorship in Brain Cancer Research and support innovative studies aimed at developing new treatments for brain tumors....more
Fred Hutch News Service • March 12, 2024
Researchers at Fred Hutchinson Cancer Center have identified a novel molecular target that could lead to more effective treatments for aggressive forms of leukemia. Their findings open new avenues for developing targeted therapies against these challenging blood cancers....more
Fred Hutch News Service • February 5, 2024
Fred Hutchinson Cancer Center is leveraging artificial intelligence (AI) and machine learning to speed up the discovery and development of new cancer immunotherapies. This initiative aims to analyze vast datasets to identify novel therapeutic targets and personalize treatments for patients....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Fred Hutchinson Cancer Center (formerly Seattle Cancer Care Alliance), are just a search away.